advertisement
11.5.2 Topical (18)
Showing records 1 to 18
Display all abstracts in classification 11.5.2 Topical
Search within classification 11.5.2 Topical69177 Latanoprost and Dorzolamide for the Treatment of Pediatric Glaucoma: The Glaucoma Italian Pediatric Study (Gipsy), Design and Baseline Characteristics
Quaranta L
Advances in Therapy 2016; 33: 1305-1315
69287 Effects of Brinzolamide, a Topical Carbonic Anhydrase Inhibitor, on Corneal Endothelial Cells
Nakano T
Advances in Therapy 2016; 33: 1452-1459
69290 Carbonic anhydrase inhibitors: a review on the progress of patent literature (2011-2016)
Lomelino C
Expert Opinion on Therapeutic Patents 2016; 26: 947-956
69287 Effects of Brinzolamide, a Topical Carbonic Anhydrase Inhibitor, on Corneal Endothelial Cells
Inoue R
Advances in Therapy 2016; 33: 1452-1459
69177 Latanoprost and Dorzolamide for the Treatment of Pediatric Glaucoma: The Glaucoma Italian Pediatric Study (Gipsy), Design and Baseline Characteristics
Biagioli E
Advances in Therapy 2016; 33: 1305-1315
69290 Carbonic anhydrase inhibitors: a review on the progress of patent literature (2011-2016)
McKenna R
Expert Opinion on Therapeutic Patents 2016; 26: 947-956
69287 Effects of Brinzolamide, a Topical Carbonic Anhydrase Inhibitor, on Corneal Endothelial Cells
Kimura T
Advances in Therapy 2016; 33: 1452-1459
69177 Latanoprost and Dorzolamide for the Treatment of Pediatric Glaucoma: The Glaucoma Italian Pediatric Study (Gipsy), Design and Baseline Characteristics
Galli F
Advances in Therapy 2016; 33: 1305-1315
69287 Effects of Brinzolamide, a Topical Carbonic Anhydrase Inhibitor, on Corneal Endothelial Cells
Suzumura H
Advances in Therapy 2016; 33: 1452-1459
69177 Latanoprost and Dorzolamide for the Treatment of Pediatric Glaucoma: The Glaucoma Italian Pediatric Study (Gipsy), Design and Baseline Characteristics
Poli D
Advances in Therapy 2016; 33: 1305-1315
69287 Effects of Brinzolamide, a Topical Carbonic Anhydrase Inhibitor, on Corneal Endothelial Cells
Tanino T
Advances in Therapy 2016; 33: 1452-1459
69177 Latanoprost and Dorzolamide for the Treatment of Pediatric Glaucoma: The Glaucoma Italian Pediatric Study (Gipsy), Design and Baseline Characteristics
Rulli E; Riva I
Advances in Therapy 2016; 33: 1305-1315
69287 Effects of Brinzolamide, a Topical Carbonic Anhydrase Inhibitor, on Corneal Endothelial Cells
Yamazaki Y
Advances in Therapy 2016; 33: 1452-1459
69177 Latanoprost and Dorzolamide for the Treatment of Pediatric Glaucoma: The Glaucoma Italian Pediatric Study (Gipsy), Design and Baseline Characteristics
Hollander L
Advances in Therapy 2016; 33: 1305-1315
69287 Effects of Brinzolamide, a Topical Carbonic Anhydrase Inhibitor, on Corneal Endothelial Cells
Yoshikawa K
Advances in Therapy 2016; 33: 1452-1459
69177 Latanoprost and Dorzolamide for the Treatment of Pediatric Glaucoma: The Glaucoma Italian Pediatric Study (Gipsy), Design and Baseline Characteristics
Katsanos A
Advances in Therapy 2016; 33: 1305-1315
69287 Effects of Brinzolamide, a Topical Carbonic Anhydrase Inhibitor, on Corneal Endothelial Cells
Tatemichi M
Advances in Therapy 2016; 33: 1452-1459
69177 Latanoprost and Dorzolamide for the Treatment of Pediatric Glaucoma: The Glaucoma Italian Pediatric Study (Gipsy), Design and Baseline Characteristics
Longo A; Uva MG; Torri V; Weinreb RN
Advances in Therapy 2016; 33: 1305-1315
